Home / 2017 / June

Month: June 2017

MedReleaf Corp gets $14 Buy Target from GMP

MedReleaf Corp (TSE:LEAF) (OTCMKTS:MEDFF) -whose shares have struggled to regain their IPO price of $9.50 a share since listing on the TSX June 15th – got a boost from GMP’s equities research group who today suggested a buy target of $14 per share.

“With two quarters of cash production costs hovering around $1.55 per gram, the company is solidifying its leading position as a low cost producer,” the research report said. “In addition, MedReleaf’s ability to mitigate the impact from the VAC’s price reimbursement cap is impressive considering the average price per gram decreased ~15% QoQ while company-wide revenues stayed stable.

The research team of Martin Landry, Andrew Partheniou, and Robert Fagan, went on to cite increased unit sales of cannabis and lower production costs of $1.53 reported in the company’s Q4 2017 financial results yesterday.…

VIDEO: Canopy Growth Corp President Mark Zekulin Talks the Future

 

Canopy Growth Corp (TSE:WEED) is the world’s largest legal marijuana growing operation, with a combined total of well over a million square feet of growing capacity across multiple locations throughout Ontario and Saskatchewan. Canopy president Mark Zekulin sheds light on how he sees the future of Canopy in the cannabis industry with the onset of legalization of cannabis consumption for recreational purposes, which by all accounts is on track for taking effect on July 1st, 2018.…

CannaRoyalty Corp CEO Marc Lustig on the Cannabis Royalty Model Copy

CannaRoyalty Corp (CNSX:CRZ) (OTCMKTS:CNNRF) (FRA:CY4) CEO Marc Lustig joins us to shed light on the factors weighing on the Cannabis sector in Canada, and tells us why his royalty model will ultimately deliver value to investors.

Transcript:

James West:    Hey, Marc, I see that you’ve been making great strides in your business model as a royalty company in the cannabis space. Your balance sheet from your last financials shows a dramatic increase in assets over the same period in the previous year, and a dramatic increase in cash, yet the stock has not reflected that. Why the juxtaposition?

Marc Lustig:   Well, I think that the stock has been under pressure, like a number of other cannabis stocks in the public markets, for the last maybe six weeks, or two months. In our case, there’s certainly nothing that I can point …

MedReleaf Corp (TSE:LEAF) (OTCMKTS:MEDFF) CEO Neil Closner makes no bones about the fact that his company's marijuana is the highest quality available in Canada. With an impressive depth of knowledge in the space, and as the country's only "significantly profitable" ACMPR grower, Neil illuminates the reasons for that positioning, and the company's plans to capture recreational market share.

MedReleaf Corp CEO Neil Closner on Growing “The Best” Marijuana in Canada Copy

MedReleaf Corp (TSE:LEAF) (OTCMKTS:MEDFF) CEO Neil Closner makes no bones about the fact that his company’s marijuana is the highest quality available in Canada. With an impressive depth of knowledge in the space, and as the country’s only “significantly profitable” ACMPR grower, Neil illuminates the reasons for that positioning, and the company’s plans to capture recreational market share.

Transcript:

James West:    Neil, thanks for joining us today.

Neil Closner:  Thank you very much. Great to be here.

James West:    Neil, maybe we could start with an overview: what is the value proposition for investors in MedReleaf?

Neil Closner:  The value proposition is that we happen to be a producer of the highest quality cannabis, we believe, in Canada. When I say ‘we believe’ that’s validated by the fact that patients, by and large, are purchasing products from us that are …

LottoGopher Holdings Powers Up Board with Kevin Harrington

LottoGopher Holdings Inc. (CNSX:LOTO) (FRA:2LG) – the lottery “gopher” service delivering tickets for PowerBall, MegaMillions and other popular lotteries in the State of California – scored a big checkmark in the management box with the addition of Kevin Harrington to its board of directors.

Harrington is the well-known celebrity business personality famous as a former original “Shark” on the business reality show “Shark Tank”.

Watch Kevin Harrington deliver a personal announcement of his joining the board of LottoGopher

“The lottery market is ripe for an update,” Harrington said. “I like to search for businesses that solve a real problem and have mass appeal. LottoGopher fits this thesis perfectly.

Harrington’s accomplishments include launching over twenty businesses that saw sales exceeding $100 million annually. Through his international business network, he’s been involved in generating over $5 billion in sales worldwide for over …

New Cannabis Ventures and 420Investor CFA Alan Brockstein joins to talk about the emerging opportunities in the Cannabis space, and how investors need to watch out as the darker underbelly of capital markets are attracted to the rich valuations currently being experienced in certain issuers.

New Cannabis Ventures and 420Investor CFA Alan Brochstein on MedReleaf, Canopy Growth, Cannabis Wheaton Copy

New Cannabis Ventures and 420Investor CFA Alan Brochstein joins to talk about the emerging opportunities in the Cannabis space such as MedReleaf Corp (TSE:LEAF) (OTCMKTS:MEDFF), Canopy Growth Corp (TSE:WEED) (OTCMKTS:TWMJF) (FRA:11L1), and Cannabis Wheaton Income Corporation (CVE:CBW) (OTCMKTS:KWFLF) (FRA:3KF)

Transcript:

James West:    Alan, thanks for joining us today.

Alan Brochstein:     I’m so excited to be here. thank you, James.

James West:    Alan, let’s start off with an overview: what is it that New Cannabis Ventures does, and what’s your revenue model?

Alan Brochstein:     Sure. So New Cannabis Ventures is actually my second cannabis effort, and the goal is to better connect cannabis investors and operators. We’re a content source; a lot of it is aggregated content, and there’s some original content as well. But what we do, James, is we save people time. We’re really focused on the cannabis industry.…

Cannabis Wheaton, MedReleaf Corp., Aurora Cannabis Lead Sector Lower

Cannabis Wheaton Income Corporation (CVE:CBW) (OTCMKTS:KWFLF) (FRA:3KF) is getting hammered today, as is MedReleaf on the first day of its IPO, despite having closed a $100 million financing. Cannabis Wheaton is already underwater on their most recent proposed financing, which saw the lead syndicate bow out after internal pressure from their respective compliance departments and Mackie Research Capital Corp step in on a best-efforts basis, while Aurora Cannabis Inc.(CVE:ACB) (OTCMKTS:ACBFF)(FRA:21P) is also taking a hit thanks to the release of a large number of escrow shares into the freely tradable float. Cannabis Wheaton is off $0.16 or 14.16 percent, trading at $0.97 in early afternoon Wednesday June 7th, which has it $0.03 below the special warrant price of $1.  Unfounded rumours circulating on the street have created a hugely negative sentiment toward the entire cannabis sector. At the heart of …

Invictus MD Strategies Chairman Dan Kriznic Podcast Interview Copy

Invictus MD Strategies Corp (CVE:IMH)(OTCMKTS:IVITF)(FRA:8IS1) Executive Chairman Dan Kriznic sat down recently and laid out the company’s goal of becoming one of the top licensed ACMPR cannabis producers in Canada.

James West:    Dan, thanks for joining me today.

Dan Kriznic:   Thanks for having me.

James West:    Dan, why don’t we start with an overview: what’s the value proposition for investors in Invictus MD Strategies Corp?

Dan Kriznic:   Yes. At this point, our main goal is to be one of the top licensed producers in Canada. We’ve since acquired over the last six months, two licensed producers, a third in Hamilton, Ontario, a company called A B Laboratories, and another one we just acquired two weeks ago, 100 percent of Acreage Farms, the second actual licensed producer out in Alberta.

James West:    Okay. So you’re a consolidator of ACMPR licensees in …

Cannabis Wheaton Financing Dead in the Water? (Updated)

Cannabis Wheaton Income Corporation (CVE:CBW) (OTCMKTS:KWFLF) (FRA:3KF)  has hit another snag in its ambitious effort to create a streaming royalty company focused on Cannabis. Unsurprising to many capital markets participants , a $50 million-upsized-to-$80 million financing that had been getting the royal treatment up and down Bay Street in favour of CBW over the last week has apparently been “mutually terminated”, sources close to the deal tell me.

However, Chuck Rifici, in response to an email seeking comment, said, “the termination was by mutual agreement and was by no way due diligence related, the financing is still on and we will be releasing further news to the market on Monday.”

I say unsurprising because members of lead underwriting investment banks such as Eight Capital and Canaccord Genuity Corp. have been identified as shareholders in the company from a previous financing …

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!